20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
Cough medicine offers hope of new treatment to slow the progression of Parkinson’s disease
10 January 2023 Following promising results reported at Phase 2 in 2020, a large-scale Phase 3 clinical trial of ambroxol, a drug currently in use to treat respiratory conditions, will start in early 2023. The ASPro-PD trial is a world-first Phase 3 trial aimed at…
Phase 3 clinical trial of ambroxol for Parkinson’s confirmed
Cure Parkinson’s is pleased to announce that a large-scale phase 3 clinical trial of ambroxol, to determine whether the drug can slow the progression of Parkinson’s.
Cure3 2023 with artists including Tracey Emin and Sir Frank Bowling
Cure Parkinson’s in association with Bonhams and Artwise are delighted to announce the fourth edition of Cure3 – the critically acclaimed selling exhibition devised to raise awareness and funds for curative Parkinson’s research. The selling exhibition will take place at Bonhams London, with a VIP…
Floral Fundraisers
Whether you have your very own green oasis or enjoy bringing a small piece of the outdoors in, there are plenty of opportunities to enjoy the best of blooms and help fundraise towards a cure for Parkinson’s. There are plenty of ways to get involved....
Year in review: 2022
At the end of each year, it is a useful process to take stock and review what we have learnt over the last 12 months. 2022 has been an extremely busy year for Parkinson’s research, with a lot of clinical trial results and new insights. As the world continues to re-open […]